Savara (SVRA) Stock Forecast, Price Target & Predictions

SVRA Stock Forecast

Savara stock forecast is as follows: an average price target of $10.00 (represents a 240.14% upside from SVRA’s last price of $2.94) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.

SVRA Price Target

The average price target for Savara (SVRA) is $10.00 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $9.00. This represents a potential 240.14% upside from SVRA's last price of $2.94.

SVRA Analyst Ratings

Buy

According to 6 Wall Street analysts, Savara's rating consensus is 'Buy'. The analyst rating breakdown for SVRA stock is 0 'Strong Buy' (0.00%), 6 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Savara Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 13, 2024	Jonathan Wolleben	JMP Securities	$9.00	$4.10	119.51%	206.12%
Jun 27, 2024	Vamil Divan	Guggenheim	$10.00	$3.84	160.42%	240.14%
Jun 27, 2024	Andrew Fein	H.C. Wainwright	$10.00	$3.84	160.42%	240.14%
Jun 27, 2024	Jonathan Wolleben	JMP Securities	$10.00	$3.96	152.53%	240.14%
May 21, 2024	Francois Brisebois	Oppenheimer	$11.00	$4.30	155.81%	274.15%

Row per page

Go to

The latest Savara stock forecast, released on Aug 13, 2024 by Jonathan Wolleben from JMP Securities, set a price target of $9.00, which represents a 119.51% increase from the stock price at the time of the forecast ($4.10), and a 206.12% increase from SVRA last price ($2.94).

Savara Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$10.00
Last Closing Price	$2.94	$2.94	$2.94
Upside/Downside	-100.00%	-100.00%	240.14%

In the current month, the average price target of Savara stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Savara's last price of $2.94. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 03, 2024	Piper Sandler	Overweight	Overweight	Hold
Oct 01, 2024	H.C. Wainwright	Buy	Buy	Hold
Aug 13, 2024	JMP Securities	Outperform	Outperform	Hold
Jun 27, 2024	Guggenheim	Buy	Buy	Hold
Jun 27, 2024	H.C. Wainwright	Buy	Buy	Hold
Jun 27, 2024	JMP Securities	Market Outperform	Market Outperform	Hold
Jun 26, 2024	Oppenheimer	Outperform	Outperform	Hold
Jun 26, 2024	Jefferies	Buy	Buy	Hold
Jun 10, 2024	Piper Sandler	Overweight	Overweight	Hold
May 21, 2024	Oppenheimer	Outperform	Outperform	Hold

Row per page

Go to

Savara's last stock rating was published by Piper Sandler on Oct 03, 2024. The company gave SVRA a "Overweight" rating, the same as its previous rate.

Savara Financial Forecast

Savara Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 16	Mar 15	Mar 07
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$46.12M	$20.00M	$5.00M	-	-	-	-	-	-	-	-	$33.30K	$28.79K	$555.57K
High Forecast	$46.12M	$20.00M	$5.00M	-	-	-	-	-	-	-	-	$39.95K	$34.54K	$666.68K
Low Forecast	$46.12M	$20.00M	$5.00M	-	-	-	-	-	-	-	-	$26.64K	$23.03K	$444.46K
# Analysts	1	1	1	-	-	-	-	-	-	-	-	19	7	13
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Savara's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. SVRA's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Savara EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 16	Mar 15	Mar 07
# Analysts	1	1	1	-	-	-	-	-	-	-	-	19	7	13
EBITDA	-	-	-	-	-	-	-	-	-	-	-	$-10.66M	$-9.59M	-
Avg Forecast	$27.67M	$12.00M	$3.00M	-	-	-	-	-	-	-	-	$-11.13M	$-9.21M	$-5.58M
High Forecast	$27.67M	$12.00M	$3.00M	-	-	-	-	-	-	-	-	$-8.90M	$-7.37M	$-4.46M
Low Forecast	$27.67M	$12.00M	$3.00M	-	-	-	-	-	-	-	-	$-13.35M	$-11.06M	$-6.70M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.96%	1.04%	-

undefined analysts predict SVRA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Savara's previous annual EBITDA (undefined) of $NaN.

Savara Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 16	Mar 15	Mar 07
# Analysts	1	1	1	-	-	-	-	-	-	-	-	19	7	13
Net Income	-	-	-	-	-	-	-	-	-	-	-	$-11.21M	$-9.62M	-
Avg Forecast	$27.54M	$2.12M	$-14.83M	$-21.18M	$-24.36M	$-22.77M	$-22.77M	$-22.77M	$-23.91M	$-23.00M	$-19.04M	$-11.64M	$-9.21M	$-5.64M
High Forecast	$27.54M	$2.12M	$-14.83M	$-21.18M	$-24.36M	$-22.77M	$-22.77M	$-22.77M	$-21.74M	$-23.00M	$-19.04M	$-9.31M	$-7.37M	$-4.51M
Low Forecast	$27.54M	$2.12M	$-14.83M	$-21.18M	$-24.36M	$-22.77M	$-22.77M	$-25.05M	$-26.08M	$-23.00M	$-19.04M	$-13.97M	$-11.05M	$-6.76M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.96%	1.04%	-

Savara's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SVRA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Savara SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 16	Mar 15	Mar 07
# Analysts	1	1	1	-	-	-	-	-	-	-	-	19	7	13
SG&A	-	-	-	-	-	-	-	-	-	-	-	$2.87M	$3.61M	-
Avg Forecast	$548.81M	$238.01M	$59.50M	-	-	-	-	-	-	-	-	$396.22K	$342.55K	$6.61M
High Forecast	$548.81M	$238.01M	$59.50M	-	-	-	-	-	-	-	-	$475.46K	$411.05K	$7.93M
Low Forecast	$548.81M	$238.01M	$59.50M	-	-	-	-	-	-	-	-	$316.97K	$274.03K	$5.29M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	7.24%	10.53%	-

Savara's average Quarter SG&A projection for Jun 24 is -, based on 0 Wall Street analysts, with a range of - to -. The forecast indicates a -100.00% fall compared to SVRA last annual SG&A of $2.87M (Mar 16).

Savara EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 16	Mar 15	Mar 07
# Analysts	1	1	1	-	-	-	-	-	-	-	-	19	7	13
EPS	-	-	-	-	-	-	-	-	-	-	-	$-4.20	$-4.20	-
Avg Forecast	$0.13	$0.01	$-0.07	$-0.10	$-0.12	$-0.11	$-0.11	$-0.11	$-0.11	$-0.11	$-0.10	$-4.54	$-3.86	$-128.34
High Forecast	$0.13	$0.01	$-0.07	$-0.10	$-0.12	$-0.11	$-0.11	$-0.11	$-0.10	$-0.11	$-0.10	$-3.63	$-3.09	$-102.67
Low Forecast	$0.13	$0.01	$-0.07	$-0.10	$-0.12	$-0.11	$-0.11	$-0.12	$-0.12	$-0.11	$-0.10	$-5.45	$-4.63	$-154.01
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.93%	1.09%	-

According to undefined Wall Street analysts, Savara's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SVRA previous annual EPS of $NaN (undefined).

Savara Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ALXO	ALX Oncology	$1.23	$24.50	1891.87%	Buy
XLO	Xilio Therapeutics	$1.02	$7.00	586.27%	Buy
AVTE	Aerovate Therapeutics	$2.67	$13.00	386.89%	Hold
VACC	Barinthus Biotherapeutics	$5.00	$22.00	340.00%	-
FENC	Fennec Pharmaceuticals	$4.28	$15.75	267.99%	Buy
SVRA	Savara	$2.94	$10.00	240.14%	Buy
GPCR	Structure Therapeutics	$32.78	$92.40	181.88%	Buy
RZLT	Rezolute	$4.95	$13.50	172.73%	Buy
STOK	Stoke Therapeutics	$11.61	$30.60	163.57%	Buy
ANAB	AnaptysBio	$19.97	$52.00	160.39%	Buy
KZR	Kezar Life Sciences	$7.38	$17.50	137.13%	Buy
DYN	Dyne Therapeutics	$29.68	$43.88	47.84%	Buy
SRRK	Scholar Rock	$27.86	$40.50	45.37%	Buy
EWTX	Edgewise Therapeutics	$31.51	$45.00	42.81%	Buy
CRNX	Crinetics Pharmaceuticals	$55.17	$70.14	27.13%	Buy
TRDA	Entrada Therapeutics	$17.77	$20.00	12.55%	Buy
RVMD	Revolution Medicines, Inc. Warrant	$56.47	$60.63	7.37%	Buy
LBPH	Longboard Pharmaceuticals	$59.84	$61.00	1.94%	Hold
ACLX	Arcellx	$87.59	$83.00	-5.24%	Buy
IKNA	Ikena Oncology	$1.68	$1.33	-20.83%	Buy
CYT	Cyteir Therapeutics	$3.02	$2.00	-33.77%	Sell

SVRA Forecast FAQ

Is Savara a good buy?

Yes, according to 6 Wall Street analysts, Savara (SVRA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 100.00% of SVRA's total ratings.

What is SVRA's price target?

Savara (SVRA) average price target is $10 with a range of $9 to $11, implying a 240.14% from its last price of $2.94. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Savara stock go up soon?

According to Wall Street analysts' prediction for SVRA stock, the company can go up by 240.14% (from the last price of $2.94 to the average price target of $10), up by 274.15% based on the highest stock price target, and up by 206.12% based on the lowest stock price target.

Can Savara stock reach $4?

SVRA's average twelve months analyst stock price target of $10 supports the claim that Savara can reach $4 in the near future.

What are Savara's analysts' financial forecasts?

Savara's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-92.683M (high $-92.683M, low $-94.961M), average SG&A $0 (high $0, low $0), and average EPS is $-0.438 (high $-0.438, low $-0.448). SVRA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $71.12M (high $71.12M, low $71.12M), average EBITDA is $42.67M (high $42.67M, low $42.67M), average net income is $-6.355M (high $-6.355M, low $-6.355M), average SG&A $846.32M (high $846.32M, low $846.32M), and average EPS is $-0.03 (high $-0.03, low $-0.03).